Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
Gabazine
|
| gptkbp:CASNumber |
117428-22-5
|
| gptkbp:discoveredBy |
Sanofi Recherche
|
| gptkbp:drugClass |
inhibits GABAA receptor activity
|
| gptkbp:effect |
blocks inhibitory neurotransmission
|
| gptkbp:hasMolecularFormula |
C20H20N4O4
|
| gptkbp:hasRole |
investigational drug
research tool |
| gptkbp:hasSMILES |
COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(C=C3)OCCN4C(=O)C5=CC=CC=C5C4=O
|
| https://www.w3.org/2000/01/rdf-schema#label |
SR-95531
|
| gptkbp:isGABAAReceptorAntagonist |
true
|
| gptkbp:isNotUsedClinically |
true
|
| gptkbp:IUPACName |
1-(2-methoxyphenyl)-4-[4-(2-phthalimidoethoxy)benzyl]piperazine
|
| gptkbp:molecularWeight |
380.4 g/mol
|
| gptkbp:PubChem_CID |
5311066
|
| gptkbp:studiedBy |
neuroscience
|
| gptkbp:synonym |
gptkb:SR95531
Gabazine |
| gptkbp:target |
gptkb:GABAA_receptor
|
| gptkbp:bfsParent |
gptkb:gabazine
|
| gptkbp:bfsLayer |
7
|